Thursday, March 28, 2024
Home Tags Eisai

Tag: Eisai

EISAI PUBLISHES SOCIETAL VALUE OF LECANEMAB USING PHASE 3 CLARITY AD...

0
TOKYO, March 19, 2023 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") today announced the publication of updated results from...

Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad...

0
TOKYO, Nov 30, 2022 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai's large global...

E.Design Insurance and Eisai Enter Into Business Alliance – Benzinga –...

0
Aiming to Promote Safe Driving and Extend Driving Life in an Aging Society Under the Theme of "Improving Brain Health (Brain Performance) For...

EISAI COMPLETES ROLLING SUBMISSION TO THE U.S. FDA FOR BIOLOGICS LICENSE...

0
TOKYO and CAMBRIDGE, Mass., May 9, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. BIIB Corporate...

Eisai Certified as the 2022 Health and Productivity Management Outstanding Organ…...

0
TOKYO, Mar 9, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been certified as the Health and Productivity...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News